The pneumococcal phosphorylcholine esterase (Pce or CbpE) is a modular protein that hydrolyses the phosphorylcholine residues present in the teichoic and lipoteichoic acids of the pneumococcal cell wall. Pce has been crystallized using the hanging-drop vapour-diffusion method at 291 K. Diffraction-quality monoclinic crystals belong to space group C2, with unit-cell parameters a = 169.82, b = 57.26, c = 67.44 A Ê , = 112.60
Introduction
Streptococcus pneumoniae is the major human Gram-positive pathogen. Many interactions with the host are mediated speci®cally by the phosphorylcholine residues present in the teichoic and lipoteichoic acids of the cell wall. These residues are recognized by components of the host response (Cundell et al., 1995; Pepis & Hirsch®eld, 2003) and serve as anchors for many surface-located proteins (Yother et al., 1992; Yother & White, 1994; Lo Â pez & Garcõ Âa, 2004 and references therein), including proteins involved in cell adhesion and virulence (Yother et al., 1992; Hammerschmidt et al., 1997; Rosenow et al., 1997; Sa Â nchez-Beato et al., 1998; Brooks-Walter et al., 1999) . The biological role of choline during infection is a subject of current interest and it has been suggested that bacteria with a lower content of choline may escape the innate clearance mechanism in the bloodstream (Yother et al., 1998; Weiser & Kapoor, 1999) . The pneumococcal pce gene encodes a teichoic acid phosphorylcholine esterase (Pce or CbpE) that removes phosphorylcholine residues from the cell-wall teichoic and lipoteichoic acids (de las Rivas et al., 2001; Vollmer & Tomasz, 2001 ). Therefore, Pce activity remodels the distribution of phosphorylcholine residues on the pneumococcal envelope, modulating the activity of choline-dependent enzymes and consequently the pathogen±host interactions. Pce carries an N-terminal signal sequence of 25 amino acids. The mature form of the protein (602 amino acids, 69 426 Da) contains a catalytic module localized in the N-terminal part of the protein and a choline-binding module at the C-terminal position that attaches the enzyme to the bacterial cell wall (de las Rivas et al., 2001; Vollmer & Tomasz, 2001) . The sequence of the catalytic module reveals a low similarity with enzymes of the /-metallohydrolase family of the -lactamase fold. The choline-binding module contains ten homologous repeating units of about 20 amino acids, similar to those found in other cholinebinding proteins (Pfam PF01473), and a long C-terminal tail of 85 residues that does not present any known similarity with sequences in protein databases. Interestingly, a Pce mutant with signi®cantly reduced colonization of the nasopharynx that was attributed to a decreased ability to adhere to human cells has been reported (Gosink et al., 2000) and Pce inactivation resulted in increased virulence in an intraperitoneal inoculation model (Vollmer & Tomasz, 2001) . Therefore, it appears that solving the Pce structure may open new therapeutic prospects for treating pneumococcal diseases. In this communication, we present preliminary results obtained by X-ray crystallography on the complete Streptococcus pneumoniae phosphorylcholine esterase.
Experimental

Pce phosphorylcholinesterase production and purification
The pce truncated mutant (PceÁ55) was constructed by cloning into plasmid pT7-7 (Tabor & Richardson, 1985) H ). The restriction sites were NdeI and BamHI. The recombinant strain culture was expressed using 50 mM isopropylthio--d-galactopyranoside as inducer in Escherichia coli strain BL21 (DE3). The DNA sequence of the pce mutant was con®rmed with an automated Abi Prism 3700 DNA sequencer (Applied Biosystems). All primers were synthesized on a Beckman Oligo 1000M synthesizer. Restriction enzymes and other DNA-modifying enzymes were purchased from Amersham. Pce phosphorylcholine esterase and its truncated form were puri®ed from cell extracts of E. coli BL21 (DE3) (pRGR12) or E. coli BL21 (DE3) (pAPM01), respectively, by af®nity chromatography on DEAE cellulose equilibrated with phosphate/Zn buffer (20 mM sodium phosphate, 3 mM ZnCO 3 pH 7.0) following the general procedure described by Sa Â nchez-Puelles et al. (1990) . The protein was speci®cally eluted using a linear gradient (0±70 mM choline in 2 h; elution rate 1 ml min À1 ) in phosphate/Zn buffer with 0.05 M NaCl. The homogeneity of the protein preparations was con®rmed by SDS±PAGE and mass spectrometry. Pce activity was assayed at 298 K using p-nitrophenylphosphorycholine (NPPC) as substrate by measuring the absorbance of the product, p-nitrophenol, at 410 nm (de las Rivas et al., 2001) . Fractions with high purity and activity were pooled and extensively dialyzed against Tris/Zn buffer (50 mM Tris±HCl, 3 mM ZnCO 3 pH 8.0) in the absence and presence of 10 mM choline. The enzyme was then concentrated at 277 K with a 10 kDa cutoff protein concentrator (Amicon, YM-10) to approximately 11 mg ml
À1
. The ®nal protein concentration was determined by spectrophotometry assuming a molar absorption coef®cient of 194 020 M À1 cm À1 at 280 nm.
Mass spectrometry
MALDI±TOF measurements were performed using a Voyager DE-PRO mass spectrometer from Applied Biosystems equipped with a pulsed nitrogen laser (! = 337 nm, 10 ns pulse width, 3 Hz frequency) and a delayed extraction ion source. Ions generated by the laser desorption were introduced into the¯ight tube (1.3 m¯ight path) with an acceleration voltage of 25 kV in the linear positive-ion mode. All mass spectra were collected by averaging the signals of 500 laser shots.
N-terminal sequencing
The N-terminal sequence of Pce and its proteolytic fragments was determined as described by Speicher (1994) using an automatic sequencer (model 477A from Applied Biosystems).
Crystallization
The initial crystallization conditions were established utilizing the sparse-matrix sampling technique (Jancarik & Kim, 1991) and the hanging-drop vapour-diffusion method at 291 K using Index Screens I and II from Hampton Research. Each hanging drop, made by mixing 1 ml protein solution and 1 ml well solution, was equilibrated against 500 ml well solution. With Pce that has been dialyzed in the presence of 10 mM choline, plate-shaped crystals were obtained in condition No. 45 of Index Screen I (0.1 M Tris pH 8.5, 25% PEG 3350). The crystals were systematically twinned thin plates that only diffracted to 3 A Ê resolution. In order to improve the crystallization process, the last 55 amino acids were deleted. The activity of the truncated form (PceÁ55) was similar to that of the wild-type protein. The initial conditions and all screens from Hampton Research were tested with the truncated form. In the absence of choline, PceÁ55 crystallized in the form of rods (Fig. 1a) under condition No. 65 of Index Screen II (0.1 M bis-Tris pH 5.5, 0.1 M ammonium acetate, 17% PEG 10K) but the crystals diffracted very poorly. Of 72 detergents and additives tested with this condition (Detergent Screens 1, 2 and 3 and Additive Screens 1, 2 and 3 from Hampton Research), only n-dodecyl phosphocholine 12 (Detergent Screen 3) produced a new crystal form (Fig. 1b) . The initial drop composition with which the best crystals were obtained was 4 ml reservoir solution (17% PEG 10 000, 0.1 M bis-Tris pH 5.5 and 0.1 M ammonium acetate), 1 ml 1.5 mM n-dodecylphosphorylcholine and 4 ml protein solution. At 293 K, crystals reached maximum dimensions of 0.1 Â 0.3 Â 0.3 mm in 15±30 d.
X-ray diffraction experiments
Diffraction data were collected from the native protein in-house on a MAR 345 image-plate detector with Cu K X-rays generated by an Enraf±Nonius rotating-anode generator equipped with a doublemirror focusing system and operated at 40 kV and 90 mA. Crystals were cryoprotected by a quick soak (10 s) in reservoir solution containing in addition 30%(v/v) glycerol.
A non-isomorphous Gd derivative was obtained by soaking the crystal for 1 min in mother liquor with 10 mM of the neutral gado- linium complex Gd-HPDO3A (Girard et al., 2003) . The optimal wavelength for data collection was taken at the white line (! = 1.7110 A Ê ) of the L III absorption edge of Gd as determined from an X-ray¯uorescence spectrum collected on the soaked crystal. A SAD data set was collected at 100 K using a CCD detector on beamline BM30A at the European Synchrotron Radiation Facility (ESRF). The crystal-to-detector distance was set to 110 mm. All data were processed and scaled using XDS (Kabsch, 1988) and SCALA from the CCP4 package (Collaborative Computational Project, Number 4, 1994) . Data-collection statistics for the Gd-HPDO3A derivative of Pce are summarized in Table 1 .
Results and discussion
The ®rst crystals of native Pce showed serious twinning problems. Careful analysis of protein stocks by SDS±PAGE and mass spectrometry showed the time-dependent appearance of two protein species corresponding to truncated forms of Pce (66.9 and 63.5 kDa) degraded at their C-terminal extreme, as con®rmed by N-terminal sequence analysis. No further decrease in Pce molecular weight was found in protein stocks after several months. Analysis of Pce crystals by SDS±PAGE using silver staining showed that only the 63.5 kDa species, which lacked the last 55 amino acids, crystallized. The C-terminal region seems to be very¯exible and no secondarystructure element is predicted for it. Therefore, in order to improve crystallization, the last 55 amino acids were deleted. The activity of the truncated form (PceÁ55) was similar to that of the wild-type protein. The best crystals of the truncated Pce form were obtained in the presence of a speci®c detergent (n-dodecylphosphorylcholine). They belong to the monoclinic space group C2, with unit-cell para- Figure 2
X-ray diffraction pattern from a Pce crystal grown using the conditions described in Fig. 1(b) (oscillation range 1  ) . The edge of the plate corresponds to 1.9 A Ê resolution. soaking in the presence of Gd-HPDO3A (Girard et al., 2003) led to derivative crystals that produced a high-quality diffraction pattern to 2.68 A Ê resolution (Fig. 2) . A total of 58 930 measured re¯ections were merged into 16 810 unique re¯ections with an overall R sym of 0.04. An anomalous Patterson map was calculated using data in the entire resolution range. The resulting v = 0 and v = 1/2 Harker sections are shown in Fig. 3 . Peaks corresponding to Gd-binding sites were clearly observed in anomalous Patterson maps and four sites were located using SHELX (Sheldrick, 1998) . Initial phases were calculated at 2.68 A Ê resolution using the program SHARP (de La Fortelle &Bricogne, 1997). Model building of the complete modular Pce is currently in progress.
